Incidence and survival of patients with malignant pancreatic neuroendocrine neoplasms in Germany, 2009–2021

202411 citationsJournal Articlehybrid Open Access

Authors

Andreas Stang · Institut für Medizinische Informatik, Biometrie und Epidemiologie

Ina Wellmann · Krebsregister Saarland

Bernd Holleczek · Krebsregister Saarland

Soo-Zin Kim-Wanner · Hess (United States)

Jacqueline Müller‐Nordhorn · Health and Safety Authority

Eunice Sirri · Regio (Germany)

Ian Wittenberg

Abstract

The incidence of pancreatic NETs has increased markedly in Germany in the period 2009-2021. Subgroups of NETs (G1 grading or localized stage) have an excellent prognosis. RS of MiNEN is more similar to NECs than NETs.

Topics & Keywords

Neuroendocrine Tumor Research Advances Lung Cancer Research Studies Neuroblastoma Research and Treatments

Publication Details

Published in: Cancer Epidemiology

Volume 93, pp. 102659-102659

DOI: 10.1016/j.canep.2024.102659

Field-Weighted Citation Impact: 4.25

Command Palette

Incidence and survival of patients with malignant pancreatic neuroendocrine neoplasms in Germany, 2009–2021

Authors

Abstract

Topics & Keywords

Publication Details